pharmacology

Peterson, Roden honored for translational medicine efforts

Josh Peterson, MD, MPH, and Dan Roden, MD, are among 10 leaders in clinical pharmacology and translational medicine recognized this week by the American Society for Clinical Pharmacology and Therapeutics.

$8.1 million grant funds new center to research highly aggressive form of lung cancer

A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.

Vanderbilt earns top rankings, including a No. 1, for successful minority recruitment in master’s and Ph.D. programs

“Diverse: Issues In Higher Education” has ranked Vanderbilt University No. 1 in the country for the number of doctoral degrees awarded to African Americans in the biological and biomedical sciences.

New faculty: David Sweatt studies how brain chemistry affects learning and memory

Homecoming came early this year for Vanderbilt alumnus David Sweatt, who joined the faculty as chair of Pharmacology this summer, 30 years after receiving his Ph.D. from the department he now leads.

Basic science, extraordinary impact

The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.

New center will examine addiction at molecular level, develop treatments

Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.

1 2 3 4